Latest articles by Daniel Koller
-
Three biotech stocks to buy now
Opinion Professional investor Daniel Koller picks three cutting edge three biotech stocks to buy now.
Opinion -
Biotech’s boom continues
Opinion Professional investor Daniel Koller picks six stocks to profit from the continuing biotech boom.
Opinion -
Five top biotech innovators
Opinion Professional investor Dr Daniel Koller picks five innovative biotech stocks to buy now.
Opinion -
Four promising biotech stocks to buy now
Opinion The recent correction in biotech stocks was overdone, says professional investor Dr Daniel Koller. Here, he picks four biotech companies to buy now.
Opinion -
Three of the best biotech stocks to buy now
Opinion Biotechnology firms are benefiting from demand from ageing populations. But as Dr Daniel Koller explains, there’s more to the biotech boom than that.
Opinion -
Biotech’s three biggest innovators
Opinion Investors can find a wide range of profitable stocks in the biotech sector. Professional investor Dr Daniel Koller tips three to buy now.
Opinion
